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Rationale & Objective: Glomerular filtration rate
(GFR) estimation based on creatinine or cystatin C
level is currently the standardmethod for assessing
GFR in epidemiologic research and clinical trials
despite several important and well-known
limitations. Plasma iohexol clearance has been
proposed as an inexpensive method for
measuring GFR that could replace estimated
GFR in many research projects. However, lack of
standardization for iohexol assays and the use of
different protocols such as single- and multiple-
sample methods could potentially hamper
comparisons across studies. We compared
iohexol assays and GFR measurement protocols
in 3 population-based European cohorts.
Study Design: Cross-sectional investigation.
Setting & Participants: Participants in the Age,
Gene/Environment Susceptibility-Kidney Study
(AGES-Kidney; n = 805), the Berlin Initiative Study
(BIS, n = 570), and the Renal Iohexol Clearance
Survey Follow-up Study (RENIS-FU; n = 1,324).
Tests Compared: High-performance liquid chro-
matography analyses of iohexol. Plasma iohexol
clearance calculated using single- versus
multiple-sample protocols.
Outcomes: Measures of agreement between
methods.4
Results: Frozen samples from the 3 studies were
obtained and iohexol concentrations were
remeasured in the laboratory at the University
Hospital of North Norway. Lin’s concordance
correlation coefficient ρ was >0.96 and Cb (ac-
curacy) was >0.99 for remeasured versus original
serum iohexol concentrations in all 3 cohorts, and
Passing-Bablok regression did not find
differences between measurements, except for
a slope of 1.025 (95% CI, 1.006-1.046) for the
log-transformed AGES-Kidney measurements.
The multiple-sample iohexol clearance
measurements in AGES-Kidney and BIS were
compared with single-sample GFRs derived
from the same iohexol measurements. Mean
bias for multiple-sample relative to single-sample
GFRs in AGES-Kidney and BIS were −0.25
and −0.15 mL/min, and 99% and 97% of
absolute differences were within 10% of the
multiple-sample result, respectively.
Limitations: Lack of comparison with an inde-
pendent gold-standard method.
Conclusions: Agreement between the iohexol
assays and clearance protocols in the 3 inves-
tigated cohorts was substantial. Our findings
indicate that plasma iohexol clearance mea-
surements can be compared across these
studies.Plasma iohexol clearance is considered a precise andaccurate method for measuring glomerular filtration
rate (GFR).1,2 Estimation of GFR from endogenous
filtration markers—such as creatinine and cystatin
C—may be affected by non-GFR determinants and lacks
precision in the high GFR range.3-6 It has been argued
that plasma iohexol clearance should be used in
research projects in which unbiased and precise GFR
results are necessary. Low cost and easy implementation
make plasma iohexol clearance a reasonable option for
both clinical trials and epidemiologic studies. However,
standardization of iohexol assays is lacking, and
different sampling protocols may lead to difficulties
comparing results across studies.
We compared iohexol assays and clearance protocols in
3 European population-based cohorts that all used pub-
lished high-performance liquid chromatography (HPLC)
methods and participated in external quality control
programs.Methods
Study Cohorts and Design
This study includes cohorts from the Age, Gene/Environ-
ment Susceptibility-Kidney Study (AGES-Kidney), Berlin
Initiative Study (BIS), and Renal Iohexol Clearance Survey
Follow-up Study (RENIS-FU), which have all been described
previously.7-9 Briefly, the 3 cohorts were recruited from
Reykjavik (Iceland), Berlin (Germany), and Tromsø (Nor-
way) and were all population based. RENIS-FU (n = 1,324)
included persons aged between 56 and 70 years; AGES-
Kidney (n = 805), between 74 and 93 years; and BIS
(n = 570), between 70 and 97 years. The 3 studies were
approved by the ethics committees of their respective in-
stitutions. They all adhered to the Declaration of Helsinki. All
participants provided written informed consent.
For the comparison of iohexol assays by remeasure-
ments in the Department of Medical Biochemistry at the
University Hospital of North Norway, random plasma andAJKD Vol 76 | Iss 1 | July 2020
Original Investigationserum samples were obtained from AGES-Kidney (sample
size = 200) and RENIS-FU (sample size = 300). Each
randomly selected participant contributed 1 measurement
to the sample, which for AGES-Kidney was drawn
randomly from all measurements for that person. Because
RENIS-FU used a single-sample protocol, persons in
RENIS-FU had only 1 measurement. From BIS (sample
size = 100), a convenience sample from all 30-minute
serum samples was obtained due to lack of frozen mate-
rial. This explains the generally higher iohexol concen-
trations in BIS samples.
To compare the single- and multiple-sample protocols
for GFR calculation, single-sample GFR was calculated
from the series of iohexol measurements in BIS and AGES-
Kidney for each person. All persons included in these 2
cohorts were eligible for these comparisons (AGES-Kidney,
n = 805; BIS, n = 570).
Iohexol Measurements
Plasma iohexol was originally measured with previously
described HPLC assays in the University of Minnesota Core
Laboratory (AGES-Kidney), and serum iohexol, in the
Department of Nephrology at the Charite Berlin, Germany
(BIS) and the Department of Medical Biochemistry at the
University Hospital of North Norway (RENIS-FU).8-10 The
methods are described in detail in Item S1. All 3 labora-
tories participated in the Equalis program for quality
control (Equalis AB). In this study, iohexol concentrations
in thawed samples from all 3 cohorts were remeasured
concurrently at the Department of Medical Biochemistry of
the University Hospital of North Norway in Tromsø,
Norway, the same laboratory used for the original mea-
surements in RENIS-FU. Median time between the original
measurements in RENIS-FU and the remeasurements was 4
years.
Calculation of GFR
AGES-Kidney and BIS used a multiple-sample iohexol
protocol with 4 (at 120, 180, 240, and 300 minutes) and 8
(same as AGES-Kidney, with additional samples at 30, 60,
90, and 150 minutes) samples, respectively, whereas the
RENIS-FU used the single-sample method.7-9 BIS calculated
GFR using the Schwartz method,11 AGES-Kidney used the
slope-intercept method with the Brøchner-Mortensen
correction,12 and RENIS-FU used a numerical method for
calculating GFR from Jacobsson’s equations.9,13 Details of
the protocols can be found in Item S2.
To compare single- and multiple-sample protocols,
Jacobsson’s method was used to calculate single-sample
GFRs from the multiple-sample measurements in BIS and
AGES-Kidney.13 For each person, interpolation on a log-
scale was used to obtain the iohexol concentration at the
optimal time point for the single-sample method. The
optimal time point was calculated using Jacobsson’s
method based on the estimated GFR derived from creati-
nine level.13 Estimated extracellular volume (ECV) dividedAJKD Vol 76 | Iss 1 | July 2020by estimated GFR corresponds to the time for the single
sample at which the influence of error from the estimated
ECV is minimized.13 Estimated GFR was calculated from
serum creatinine level using the Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) equation.14 ECV
was estimated using Granerus’ equation.15 Participants
were excluded if the exponential decay of measured
iohexol concentration over time for either the fast or slow
component had a Pearson correlation of log iohexol versus
time ≥ −0.85 (4 participants in AGES-Kidney and 8 in BIS).
Also, participants with missing iohexol data for the slow
component were excluded (9 participants in AGES-Kidney
and none in BIS). Thus, 792 persons in AGES-Kidney and
562 persons in BIS were included in the analyses.
Statistical Methods
We used Bland-Altman analysis, Passing-Bablok regression,
and Lin’s concordance correlation coefficient to compare 1
repeated measurement with 1 original measurement of
iohexol for each selected person in each cohort.16-18 In
Bland-Altman analysis, bias is expressed as the mean of the
differences between the remeasured and original iohexol
concentrations, and limits of agreement, as the mean ± 2
times the standard deviation (SD) of the differences. Bland
and Altman’s method was used for estimating 95% con-
fidence intervals for bias and limits of agreement.19
The necessary sample sizes for the Passing-Bablok re-
gressions were calculated using Linnet’s method for
Deming regression because sample size calculation for
Passing-Bablok regression is not readily available, although
simulations of power for small sample sizes have been
published.20-22 We assumed constant and identical co-
efficients of variation (CVs) of 3% for all 3 cohorts. Range
ratios (maximum divided by minimum observed original
iohexol measurement) were 8.1, 14.1, and 3.0 for AGES-
Kidney, BIS, and RENIS-FU, respectively. A higher range
ratio requires a lower sample size to detect a deviation with
the same power. To obtain sufficiently precise estimates for
the calibration equations between cohorts, we aimed to
detect a deviation from zero for the intercept of 1, and a
deviation in slope from unity of 0.05 with alpha of 0.05
and power of 0.90. Because we assumed that Passing-
Bablok regression, which is a nonparametric method, has
lower power than a Deming regression, we also assumed
that sample sizes should be increased for the Passing-
Bablok regressions. By Linnet’s method,21 sample sizes of
200 from AGES Kidney, 100 from BIS, and 300 from
RENIS-FU satisfy this requirement by a wide margin when
using his method for measurement with proportional SDs.
However, because Passing-Bablok regressions with log-
transformed measurements were performed after inspec-
tion of the data, we recalculated the necessary sample sizes.
Using log-transformed data, range ratios were reduced to
1.6, 1.7, and 1.3 for AGES-Kidney, BIS, and RENIS-FU,
respectively. The requirements to detect deviations of 1
for the intercept and 0.05 for the slope were recalculated55
Table 1. Characteristics of the Population-Based Cohorts
AGES-Kidney BIS RENIS-FU
No. of participants 805 570 1,324
Age, y 80.3 ± 4.0 78.5 ± 6.2 63.6 ± 4.0
Male sex 355 (44.1%) 326 (57.2%) 657 (49.6%)
Body weight, kg 77.0 ± 14.1 77.3 ± 13.9 79.4 ± 14.3
Height, cm 167.7 ± 9.4 166.3 ± 8.5 170.6 ± 8.7
BMI, kg/m2 27.4 ± 4.3 27.9 ± 4.2 27.2 ± 4.1
BSA, m2 1.86 ± 0.20 1.85 ± 0.19 1.91 ± 0.19
Absolute GFR, mL/mina 66.3 ± 19.1 64.7 ± 19.3 98.5 ± 19.8
BSA-adjusted GFR, mL/min/1.73 m2a
Mean 61.6 ± 16.3 60.3 ± 16.4 89.1 ± 14.5
≤30 33 (4%) 17 (3%) 2 (0.2%)
30-60 302 (38%) 256 (45%) 33 (2%)
60-75 307 (38%) 203 (36%) 169 (13%)
>75 163 (20%) 94 (16%) 1,120 (85%)
Note: Except when indicated otherwise, data are shown as mean ± standard deviation or count (percent).
Abbreviations: AGES-Kidney, Age, Gene/Environment Susceptibility-Kidney Study; BIS, Berlin Initiative Study; BMI, body mass index; BSA, body surface area; GFR,
glomerular filtration rate; RENIS-FU, Renal Iohexol-Clearance Survey Follow-up.
aFor AGES-Kidney, recalibrated values according to the Passing-Bablok regression in Table 2 are given.
Original Investigationto corresponding requirements at the log scale mean for
each cohort. Whereas slope requirements were identical at
0.049 for all 3 cohorts, intercept requirements were now
0.01, 0.005, and 0.02 for AGES-Kidney, BIS, and RENIS-
FU, respectively. Using Linnet’s table for power of 90%
with constant SDs,21 the necessary sample sizes were found
to be lower for the slope but higher for the intercept than
those used in our study. This means that the actual power
was <90% to detect deviations in the intercepts, but >90%
to detect deviations in the slopes.
Bland-Altman analysis, Passing-Bablok regression, Lin’s
concordance correlation coefficient, and concordance
within 5% and 10% were used to study agreement
between single- and multiple-sample GFRs in the AGES-
Kidney and BIS cohort. Concordance was defined as per-
centage of absolute differences between the multiple- andAGES-Kidney (n=805) BIS (n=5
Random sample (n=200)
AGES-Kidney study





Figure 1. Inclusion of iohexol samples from the Age, Gene/Environ
Study (BIS), and Renal Iohexol-Clearance Survey Follow-up (RENIS
istry at the University Hospital of North Norway (UNN).
56single-sample results of less than 5% or 10% of the original
multiple-sample result. Differences in concordance across
categories of body mass index (BMI) were compared using
a logistic regression model with concordance for each
participant (yes/no) as the dependent variable and vari-
ables for cohort, BMI, and their interaction as independent
variables. Statistical significance of the variable for BMI
and/or the interaction was taken to indicate a difference
across BMI categories.
The same method was used for testing differences in
concordance across categories of GFR. GFR categories were
based on the mean of the multiple- and single-sample GFR
measurements for each person. We also carried out Bland-
Altman analysis, Passing-Bablok regression, and estimated
Lin’s concordance correlation coefficient in the GFR sub-
groups. Absolute GFRmeasured inmL/minwas used in these70) RENIS-FU (n=1324)
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Study populaon for comparison between
mulple- and single sample protocol (n=1354)
Excluded because of 
missing iohexol data for 
the slow component (n=9) 
Excluded because 
correlaon of log iohexol 
vs. me ≥-0.85 (n=4) Excluded because 
correlaon of log iohexol 
vs. me ≥-0.85 (n=8)
Figure 2. Inclusion of study participants from the Age, Gene/Environment Susceptibility-Kidney Study (AGES-Kidney) and Berlin
Initiative Study (BIS) cohorts for comparison between the multiple- and single-sample protocols for measuring glomerular filtration
rate as iohexol clearance.
Original Investigationanalyses, but GFR adjusted for body surface area calculated
using the equation of Dubois is included in Table 1.23 We
used R, version 3.5.1 (R Foundation for Statistical
Computing). Statistical significance was set at P < 0.05.Results
Cohort Characteristics
Characteristics of the 3 cohorts are shown in Table 1.
Flowcharts of the inclusion of samples and participants for
remeasurements of iohexol and for comparison of the
multiple- and single-sample protocols are shown in






AGES-Kidney 200 2.1% (1.3% to 2.9%)
BIS 98 0.5% (−0.2% to 1.2%)





AGES-Kidney −0.091 (−0.181 to 0.001)
BIS 0.031 (−0.103 to 0.177)
RENIS-FU −0.023 (−0.158 to 0.101)
Lin's Concordance
Correlation Coefficientb ρ (95% CI)
AGES-Kidney 0.991 (0.988 to 0.993)
BIS 0.994 (0.991 to 0.996)
RENIS-FU 0.961 (0.952 to 0.969)
Note: Iohexol was measured in plasma in AGES-Kidney and in serum in BIS and RE
Abbreviations: AGES-Kidney, Age, Gene/Environment Susceptibility-Kidney Study; B
Survey Follow-up.
aAgreement analyzed on the log-transformed scale. Bias is expressed as percent cha
bLin's concordance correlation coefficient measures deviations from identity between 2
1 correspond to perfect precision and accuracy.
AJKD Vol 76 | Iss 1 | July 2020Iohexol Measurements
Two measurements from BIS demonstrated differences
between the original and remeasured iohexol-
concentrations of 109 and 55 mg/L. These extreme out-
liers were believed to be results from procedural errors and
were excluded from further analyses. Table 2 and Figure 3
show comparisons between the remeasured and original
results of the HPLC measurements. Mean CVs between the
original and remeasured iohexol values were 3.5%, 1.8%,
and 3.2% for AGES-Kidney, BIS, and RENIS-FU, respec-
tively. Because we remeasured a single sample from each
individual in AGES-Kidney and BIS, GFR based on





−8.6% (−9.8% to −7.3%) 14.0% (12.5% to 15.6%)
−5.8% (−6.9% to −4.7%) 7.3% (6.1% to 8.5%)
−11.5% (−12.5% to −10.4%) 11.5% (10.2% to 12.8%)
Slope
(95% CI)
1.025 (1.006 to 1.046)
0.995 (0.968 to 1.020)






IS, Berlin Initiative Study; CI, confidence interval; RENIS, Renal Iohexol-Clearance
nge in remeasured iohexol relative to the original measurement.
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Figure 3. Scatterplots and Bland-Altman plots of original and remeasured log-transformed serum/plasma iohexol concentrations for
the Age, Gene/Environment Susceptibility-Kidney Study (AGES-Kidney), Berlin Initiative Study (BIS), and Renal Iohexol-Clearance
Survey Follow-up (RENIS-FU) Study cohorts. To the left, the remeasured iohexol concentrations are plotted against the original re-
sults with identity indicated as a solid line. To the right, percentage change in remeasured iohexol concentrations relative to the orig-
inal results are plotted against the geometric mean of the 2. Mean bias and lower and upper limits of agreement are plotted as
dashed lines, and 95% confidence intervals, by dotted lines.
Original Investigationcohorts. The CV for recalculated single-sample GFRs in
RENIS-FU was 2.6%.
Iohexol concentrations were log-transformed before
the Bland-Altman and Passing-Bablok regression analyses
because of a skewed distribution. When expressed as
percentage changes, Bland-Altman analyses revealed bias
of the remeasured values of −0.7% to 2.1%, relative to
the original measurements for the 3 cohorts. Limits of
agreement for the BIS cohort were narrower than for the
other 2 cohorts. In the Passing-Bablok regression, the
slope for the AGES-Kidney cohort indicated a significant
difference between the remeasured and original values,
but there were no significant differences for the other
cohorts (Table 2). When we recalculated GFR with a
corresponding calibration of the AGES-Kidney iohexol
concentrations, the difference between mean values of
the original (67.22 mL/min) and recalculated GFRs
(66.35 mL/min) was only 0.87 mL/min. Lin’s concor-
dance correlation coefficient ρ (precision) was >0.96 and58Cb (accuracy) was >0.99 for all 3 cohorts (Table 2). The
accuracy statistic Cb measures how far the best-fit line to
the data deviates from the line of identity.18 According to
McBride’s proposed criteria for ρ, this level of agreement
is characterized as substantial.24
Multiple- Versus Single-Sample Plasma Iohexol
Clearance Protocols
The comparison between multiple- and single-sample
protocols is shown in Table 3 and Figure 4. In Bland-
Altman analyses, mean bias was −0.25 ± 1.46 (SD) mL/
min for the AGES-Kidney and −0.15 ± 3.16 mL/min for
the BIS cohort. Passing-Bablok regression demonstrated
slight deviations from the line of identity for both cohorts.
Lin’s concordance correlation coefficients indicated sub-
stantial agreement between multiple- and single-sample
GFRs in both cohorts (Table 3).24 The percentage of ab-
solute differences between multiple- and single-sample
results within 5% of the multiple-sample results wasAJKD Vol 76 | Iss 1 | July 2020




AGES-Kidney 792 66.3 ± 19.1 66.6 ± 19.3
BIS 562 64.8 ± 19.2 64.9 ± 18.6
Bland-Altman Analyses





AGES-Kidney −0.25 (−0.36 to −0.15) −3.11 (−3.29 to −2.94) 2.61 (2.43 to 2.78)
BIS −0.15 (−0.41 to 0.11) −6.34 (−6.78 to −5.89) 6.03 (5.59 to 6.48)
Passing-Bablok
Regressionc Intercept (95% CI) Slope (95% CI)
AGES-Kidney 0.26 (0.10 to 0.43) 0.99 (0.99 to 1.00)
BIS −1.08 (−1.81 to −0.39) 1.02 (1.01 to 1.03)
Lin's Concordance Correlation Coefficientd ρ (95% CI) Cb
AGES-Kidney 0.997 (0.997 to 0.997) 1.000
BIS 0.986 (0.984 to 0.988) 0.999
Concordance Within 5% and 10%e 5% 10%
AGES-Kidney 95% 99%
BIS 78% 97%
Abbreviations: AGES-Kidney, Age, Gene/Environment Susceptibility-Kidney Study; BIS, Berlin Initiative Study; CI, confidence interval; GFR, glomerular filtration rate.
aValues given as mean ± standard deviation.
bGFR measured in mL/min. Bias is defined as the mean of multiple- minus single-sample iohexol clearances.
cDependent variable is multiple-sample GFR, independent variable is single-sample GFR.
dLin's concordance correlation coefficient measures deviations from identity between 2 measurements where ρ expresses precision and Cb expresses accuracy. Values of
1 correspond to perfect precision and accuracy.
eConcordance defined as the percentage of absolute differences between the multiple- and single-sample results less than 5% or 10% of the original multiple-sample
result.
Original Investigationlower for BIS than for AGES-Kidney (78% vs 95%), but the
proportion within 10% was similar (97% vs 99%).
Because variability in the interpolated iohexol value
used to calculate single-sample GFR will be lower than in
the case of a single measurement, sensitivity analysis was
performed in which the iohexol measurement closest to
the optimal sampling time was used instead. This yielded
mean bias of 1.06 ± 2.51 mL/min for AGES-Kidney and
1.08 ± 3.96 mL/min for BIS.
No statistically significant variation in concordance
across BMI categories was observed for the 2 cohorts
(Table S1), and Lin’s concordance correlation coefficient
was >0.99 for AGES-Kidney and >0.97 for BIS across all
categories. There was a small statistically significant nega-
tive bias for the lowest BMI category for both cohorts
(−0.51 mL/min for AGES-Kidney and −1.11 mL/min for
BIS). For BIS, there was also a statistically significant pos-
itive bias of 1.93 mL/min for the highest BMI category.
Passing-Bablok regression demonstrated a corresponding
tendency for a deviation from the line of identity for the
highest BMI category in BIS, but this was not statistically
significant (Table S1).
There were statistically significant differences across
GFR categories for samples within 5% concordance, with
AGES-Kidney demonstrating a generally high percentage of
samples within 5% concordance across all GFR categories,
with a trend toward greater concordance at high GFRs,AJKD Vol 76 | Iss 1 | July 2020while BIS showed greatest concordance at low GFRs, with
a significant decrease in concordant samples at higher GFRs
(P for interaction = 0.001; Table S2). This is also reflected
in the Bland-Altman analysis, Passing-Bablok regression,
and Lin’s concordance correlation coefficients for BIS,
which indicate somewhat lower agreement for high GFRs.
However, bias was <1 mL/min for the 2 highest cate-
gories, and there were no statistically significant differ-
ences across GFR categories for samples within 10%
concordance for any of the cohorts (Table S2).Discussion
We found substantial agreement when comparing
different methods for measuring iohexol concentrations
and iohexol clearance in 3 population-based cohorts,
which compares favorably with interlaboratory compari-
sons of common clinical chemistry tests, for example,
serum creatinine.25 The results also indicate that serum or
plasma iohexol frozen at −80C is stable. Our results
compare favorably with the 2 other studies of interlabor-
atory agreement for HPLC iohexol analysis that we are
aware of.26,27 The slightly better outcome observed for the
BIS cohort may have resulted from greater precision for the
higher iohexol concentrations in the samples. The devia-
tion from unity of the slope in the Passing-Bablok








































































Figure 4. Scatterplots and Bland-Altman plots of multiple- and single-sample glomerular filtration rates (GFRs; mL/min) for the Age,
Gene/Environment Susceptibility-Kidney Study (AGES-Kidney) and Berlin Initiative Study (BIS) cohorts. The series of multiple-
sample iohexol concentrations have been used for calculating single-sample GFR for each person. To the left, multiple-sample is
plotted against single-sample GFR with identity indicated as a solid line. To the right, the difference between multiple- and single-
sample GFRs is plotted against the mean of the 2. Mean bias and lower and upper limits of agreement are plotted as dashed lines,
and 95% confidence intervals, by dotted lines.
Original Investigationrecalculated GFR of only 0.87 mL/min when iohexol
concentrations were recalibrated.
Previous comparisons of multiple- and single-sample
protocols have also demonstrated good agreement. In
comparisons based on the same series of iohexol con-
centration measurements, bias has been found within the
range of −0.2 to 4 mL/min/1.73 m2 with limits of
agreement comparable to our results.28-31 Two studies
compared both the single- and multiple-sample methods
with an independent multiple-sample 51Cr-EDTA clear-
ance and observed similar performances for both
methods.31,32 Although very small differences between
the 2 methods were found in both the AGES-Kidney and
BIS cohorts, the SD of the distribution was greater in BIS
than in AGES-Kidney. The explanation could be that
Jacobsson’s single-sample method is directly derived
from the Brøchner-Mortensen method used in AGES-
Kidney, whereas a 2-compartment model was used in
BIS.60It has been suggested that the single-sample method is
questionable in persons with extremes of body weight
because it calculates the ECV from weight and sex using the
Graneus’ equation.2,33 Although there was a tendency to-
ward smaller 5% concordance for low and high BMI in the
present study, this was not statistically significant, and
results for 10% concordance were >92% for all BMI cate-
gories. Hence, any bias for the single-sample method at the
extremes of weight is probably small and can be mini-
mized by using the optimal sampling time, as outlined by
Jacobsson.13 This is the time point at which the influence
from error in the ECV estimate is at its minimum.
There was a statistically significant difference in 5%
concordance between single- and multiple-sample
methods for categories of GFR, but with opposite trends
for AGES-Kidney and BIS (Table S2). The lower 5%
concordance for high GFRs in BIS can probably be
explained by the use of different multiple-sample methods
in AGES-Kidney and BIS, whereas comparison with anAJKD Vol 76 | Iss 1 | July 2020
Original Investigationindependent gold-standard technique would be necessary
to decide which of the methods is superior. The 10%
concordance was ≥95% across all GFR categories for both
methods.
The most important limitation of the present study is
the inability to compare original and remeasured GFRs
in the AGES-Kidney and BIS cohorts because only 1
iohexol sample from each multiple-sample series was
remeasured for each participant. In RENIS-FU, the CV of
recalculated GFR from the remeasured single samples
can be compared to the CV of interindividual day-to-day
variation in GFR (2.6% vs 4.2%), established in a pre-
vious study of the same cohort.34 By calculating the
corresponding variance from the mean GFR observed in
that analysis (94 mL/min),34 we can estimate that ~38%
of the total day-to-day variance in GFR can be attributed
to measurement error, and the rest, to intraindividual
biological variation. This result should nevertheless be
interpreted with caution because several authors have
reported higher CVs for the total day-to-day variation, in
the range of 5% to 10%.2 Both measurement error and
biological fluctuations probably vary between different
research settings.
Another limitation of the present study is the lack of
comparison to an independent gold-standard method.
Although comparable, we cannot exclude the possibility
that the methods in all 3 centers are biased. However,
because previous comparisons of iohexol clearance with
renal inulin clearance have found a median bias of 3%
(95% confidence interval, 0%-6%), a common bias for the
3 cohorts is probably small.1 It should be noted that the
present study included few persons with very low GFRs,
which may limit the generalizability of results to patients
in this category.
We conclude that the HPLC assays in the 3 investigated
cohorts yielded almost identical iohexol values and that
multiple- and single-sample plasma iohexol clearance
methods based on these measurements were highly
comparable.Supplementary Material
Supplementary File (PDF)
Item S1: HPLC for iohexol measurement.
Item S2: Methods for calculating plasma iohexol clearance.
Table S1: Agreement statistics for comparison of multiple and single
sample GFR calculations according to cohort and BMI category.
Table S2: Agreement statistics for comparison of multiple and single
sample GFR calculations according to cohort and GFR category.
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